Hydrosome Labs, a pioneering Chicago-based B-to-B biotechnology company, has successfully raised $3.7 million in its latest funding round. This investment will significantly bolster the company’s mission to revolutionize the way we interact with water through its groundbreaking technology, Hydrosome H2O. By leveraging the emerging science of ultrafine bubbles, Hydrosome Labs has created a natural and chemical-free process that enhances the efficacy of water, delivering active ingredients to cells in a more efficient and complete manner. With a wide array of applications ranging from personal care and cosmetics to beverages, precision fermentation, and controlled environment agriculture, Hydrosome H2O is poised to transform multiple industries. The funding will support the scaling up of operations, enabling the company to continue innovating and advancing its technology. It is particularly exciting as Hydrosome H2O not only promotes healthier and faster plant growth while reducing fertilizer use, but also enhances nutrient absorption in skincare products, offers improved hydration in performance drinks, and achieves better yields in precision fermentation. Additionally, this technology empowers manufacturers to reduce their chemical usage, minimize environmental impact, and streamline supply chains. With a leadership team comprised of experienced executives from Fortune 500 companies such as Procter & Gamble, Goldman Sachs, and Nestlé Health Sciences, as well as the Intercontinental Exchange, which owns the New York Stock Exchange, Hydrosome Labs is well-positioned to drive significant change in the biotechnology space. For more information on this innovative company and its game-changing technology, visit www.hydrosomelabs.com.










